A Personalized Behavioral Intervention to Improve Physical Activity, Sleep and Cognition in Sedentary Older Adults
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Sleep
- Sponsor
- Johns Hopkins University
- Enrollment
- 129
- Locations
- 1
- Primary Endpoint
- Change in Objective Sleep Duration
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Cognitive decline and sleep complaints are prevalent in older adults and severely affect older adults' physical health and quality of life. Sedentary lifestyle, which is reported by 90% of older Americans, is an important risk factor for both cognitive decline and sleep disturbances. Although promoting physical activity has benefits to older adults' health, including sleep and cognition, traditional interventions to increase activity are challenging due to extensive staffing requirements and low adherence. Electronic activity monitors, such as wrist-worn accelerometers, can track heart rate, activity, and sleep to allow individuals to work towards personal activity and sleep goals. These appealing features make these devices ideal for interventions that aim to change behaviors and improve health outcomes. However, the efficacy of using electronic activity monitors to promote physical activity and health in older adults has not been examined.
The investigators will conduct a randomized controlled trial in a cohort of older adults (without dementia) with both sedentary lifestyle and nocturnal sleep complaints to examine the effectiveness of a personalized behavioral intervention (compared to a control group) embedded within a smart watch application in older adults. 94 cognitively intact elders and 21 older adults with mild cognitive impairment will be enrolled and randomly allocated to the intervention or control group. Participants in the intervention arm will receive in person exercise training sessions, and personalized, self-monitor physical activity, receive interactive prompts, biweekly phone consultation with the research team, and financial incentives for achieving weekly physical activity goals. The control group will receive general education on physical activity in older adults and continue the routine daily activity during the intervention period. The intervention for older adults without cognitive impairment is 24 weeks and for older adults with mild cognitive impairment is 16 weeks.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Intact cognition or mild cognitive impairment
- •Poor sleep quality
- •Approval from healthcare provider to engage in mild to moderate physical activity
- •More than 5 hours of self-reported sedentary time per day
- •Understands English
Exclusion Criteria
- •Untreated sleep apnea as diagnosed by polysomnography
Outcomes
Primary Outcomes
Change in Objective Sleep Duration
Time Frame: Week 1, Week 26 intact cognition or Week 18 for mild cognitive impairment (MCI)
Total Sleep time (minutes) will be measured using actigraph
Change in Plasma interleukin-1ß (IL-1ß)
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
The IL-1ß (pg/mL) will be measured using Plasma from blood draw
Change in Global Cognition As Assessed by The Cogstate Brief Battery (CBB)
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
The Cogstate Brief Battery (CBB) will be used as the primary assessment of cognitive function. The CBB is a computer based cognitive battery that scores four core cognitive domains: processing speed, attention/vigilance, visual learning memory and visual working memory. The composite cognition score is the primary cognition measure used to measure global cognitive function. The score will range from 0-400, with a higher score indicating higher performance.
Change in Sleep Efficiency as Assessed by Actigraphy
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
Sleep efficiency (reported as a percentage) will be measured using actigraphy
Change in Subjective Sleep Quality as Assessed by the Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
The PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
Change in Physical Activity (PA) as assessed by the Physical Activity Scale for the Elderly
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
Subjective PA will be obtained from the Physical Activity Scale for the Elderly. Score ranges from 0-400. The higher the score the higher the physical activity level.
Change in Plasma C-reactive protein (CRP)
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
The CRP (pg/mL) will be measured using Plasma from blood draw
Change in Plasma tumor necrosis factor-α (TNF-α)
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
The TNF (pg/mL) will be measured using Plasma from blood draw
Change in Plasma interleukin-6 (IL-6)
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
The IL-6 (pg/mL) will be measured using Plasma from blood draw
Change in Physical Activity (PA) as Assessed by Actigraphy
Time Frame: Week 1, Week 26 intact cognition or Week 18 for MCI
The Actigraphy (counts/min) will be used as a standardized research tool for PA assessment. Higher counts/min indicate higher level of physical activity.